APO Research
Talk to an analyst

APO RESEARCH · REPORT

Omega-3 Fatty Acid Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Omega-3 Fatty Acid Drugs Market Outlook and Growth Opportunities 2026

29 December 2025205 pages

Choose your research edition.

Industry ResearchOmega-3 Fatty Acid Drugs Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Omega-3 Fatty Acid Drugs Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Omega-3 Fatty Acid Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Omega-3 Fatty Acid Drugs Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Omega-3 Fatty Acid Drugs Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Omega-3 Fatty Acid Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Omega-3 Fatty Acid Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Omega-3 Fatty Acid Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Omega-3 Fatty Acid Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Omega-3 Fatty Acid Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Omega-3 Fatty Acid Drugs market include Teva, Sichuan Gowell Pharmaceutical, Humanwell Puracap Pharmaceuticals, Qilu Pharmaceutical, Jiangsu Wangao Pharmaceutical, Chengdu Suncadia Medicine, Zydus, Woodward Pharma and Sun Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Omega-3 Fatty Acid Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Omega-3 Fatty Acid Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Omega-3 Fatty Acid Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Omega-3 Fatty Acid Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Omega-3 Fatty Acid Drugs Segment by Company

Teva

Sichuan Gowell Pharmaceutical

Humanwell Puracap Pharmaceuticals

Qilu Pharmaceutical

Jiangsu Wangao Pharmaceutical

Chengdu Suncadia Medicine

Zydus

Woodward Pharma

Sun Pharma

Strides Pharma

PuraCap Pharmaceuticals

Mankind Pharma

Hikma

GLW Pharma

Dr. Reddy's Laboratories

Ascent Pharmaceuticals

Apotex

Amneal Pharmaceuticals

Amarin Pharmaceuticals

Omega-3 Fatty Acid Drugs Segment by Type

EPA

EPA and DHA

Omega-3 Fatty Acid Drugs Segment by Application

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Omega-3 Fatty Acid Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Omega-3 Fatty Acid Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Omega-3 Fatty Acid Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Omega-3 Fatty Acid Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Omega-3 Fatty Acid Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Omega-3 Fatty Acid Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Omega-3 Fatty Acid Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Omega-3 Fatty Acid Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Omega-3 Fatty Acid Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Omega-3 Fatty Acid Drugs industry.

Chapter 3: Detailed analysis of Omega-3 Fatty Acid Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Omega-3 Fatty Acid Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Omega-3 Fatty Acid Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Omega-3 Fatty Acid Drugs Industry Trends Table 2. Omega-3 Fatty Acid Drugs Industry Drivers Table 3. Omega-3 Fatty Acid Drugs Industry Opportunities and Challenges Table 4. Omega-3 Fatty Acid Drugs Industry Restraints Table 5. Global Omega-3 Fatty Acid Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Omega-3 Fatty Acid Drugs Revenue Share by Company (2021-2026) Table 7. Global Omega-3 Fatty Acid Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Omega-3 Fatty Acid Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Omega-3 Fatty Acid Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Omega-3 Fatty Acid Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Omega-3 Fatty Acid Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Omega-3 Fatty Acid Drugs Company, Product Type & Application Table 13. Global Omega-3 Fatty Acid Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Omega-3 Fatty Acid Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of EPA Table 18. Significant Companies of EPA and DHA Table 19. Global Omega-3 Fatty Acid Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Omega-3 Fatty Acid Drugs Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Omega-3 Fatty Acid Drugs Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Omega-3 Fatty Acid Drugs Sales Volume Share by Type (2021-2026) Table 23. Global Omega-3 Fatty Acid Drugs Sales Volume Share by Type (2027-2032) Table 24. Global Omega-3 Fatty Acid Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Omega-3 Fatty Acid Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Omega-3 Fatty Acid Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Omega-3 Fatty Acid Drugs Sales Value Share by Type (2021-2026) Table 28. Global Omega-3 Fatty Acid Drugs Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Pharmacy Table 30. Significant Companies of Retail Pharmacy Table 31. Significant Companies of Online Pharmacy Table 32. Global Omega-3 Fatty Acid Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Omega-3 Fatty Acid Drugs Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Omega-3 Fatty Acid Drugs Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Omega-3 Fatty Acid Drugs Sales Volume Share by Application (2021-2026) Table 36. Global Omega-3 Fatty Acid Drugs Sales Volume Share by Application (2027-2032) Table 37. Global Omega-3 Fatty Acid Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Omega-3 Fatty Acid Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Omega-3 Fatty Acid Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Omega-3 Fatty Acid Drugs Sales Value Share by Application (2021-2026) Table 41. Global Omega-3 Fatty Acid Drugs Sales Value Share by Application (2027-2032) Table 42. Global Omega-3 Fatty Acid Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Omega-3 Fatty Acid Drugs Sales by Region (2021-2026) & (K Units) Table 44. Global Omega-3 Fatty Acid Drugs Sales Market Share by Region (2021-2026) Table 45. Global Omega-3 Fatty Acid Drugs Sales by Region (2027-2032) & (K Units) Table 46. Global Omega-3 Fatty Acid Drugs Sales Market Share by Region (2027-2032) Table 47. Global Omega-3 Fatty Acid Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Omega-3 Fatty Acid Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Omega-3 Fatty Acid Drugs Sales Value Share by Region (2021-2026) Table 50. Global Omega-3 Fatty Acid Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Omega-3 Fatty Acid Drugs Sales Value Share by Region (2027-2032) Table 52. Global Omega-3 Fatty Acid Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Omega-3 Fatty Acid Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Omega-3 Fatty Acid Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Omega-3 Fatty Acid Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Omega-3 Fatty Acid Drugs Sales by Country (2021-2026) & (K Units) Table 57. Global Omega-3 Fatty Acid Drugs Sales Market Share by Country (2021-2026) Table 58. Global Omega-3 Fatty Acid Drugs Sales by Country (2027-2032) & (K Units) Table 59. Global Omega-3 Fatty Acid Drugs Sales Market Share by Country (2027-2032) Table 60. Global Omega-3 Fatty Acid Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Omega-3 Fatty Acid Drugs Sales Value Market Share by Country (2021-2026) Table 62. Global Omega-3 Fatty Acid Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Omega-3 Fatty Acid Drugs Sales Value Market Share by Country (2027-2032) Table 64. Teva Company Information Table 65. Teva Business Overview Table 66. Teva Omega-3 Fatty Acid Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Teva Omega-3 Fatty Acid Drugs Product Portfolio Table 68. Teva Recent Development Table 69. Sichuan Gowell Pharmaceutical Company Information Table 70. Sichuan Gowell Pharmaceutical Business Overview Table 71. Sichuan Gowell Pharmaceutical Omega-3 Fatty Acid Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Sichuan Gowell Pharmaceutical Omega-3 Fatty Acid Drugs Product Portfolio Table 73. Sichuan Gowell Pharmaceutical Recent Development Table 74. Humanwell Puracap Pharmaceuticals Company Information Table 75. Humanwell Puracap Pharmaceuticals Business Overview Table 76. Humanwell Puracap Pharmaceuticals Omega-3 Fatty Acid Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Humanwell Puracap Pharmaceuticals Omega-3 Fatty Acid Drugs Product Portfolio Table 78. Humanwell Puracap Pharmaceuticals Recent Development Table 79. Qilu Pharmaceutical Company Information Table 80. Qilu Pharmaceutical Business Overview Table 81. Qilu Pharmaceutical Omega-3 Fatty Acid Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Qilu Pharmaceutical Omega-3 Fatty Acid Drugs Product Portfolio Table 83. Qilu Pharmaceutical Recent Development Table 84. Jiangsu Wangao Pharmaceutical Company Information Table 85. Jiangsu Wangao Pharmaceutical Business Overview Table 86. Jiangsu Wangao Pharmaceutical Omega-3 Fatty Acid Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Jiangsu Wangao Pharmaceutical Omega-3 Fatty Acid Drugs Product Portfolio Table 88. Jiangsu Wangao Pharmaceutical Recent Development Table 89. Chengdu Suncadia Medicine Company Information Table 90. Chengdu Suncadia Medicine Business Overview Table 91. Chengdu Suncadia Medicine Omega-3 Fatty Acid Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Chengdu Suncadia Medicine Omega-3 Fatty Acid Drugs Product Portfolio Table 93. Chengdu Suncadia Medicine Recent Development Table 94. Zydus Company Information Table 95. Zydus Business Overview Table 96. Zydus Omega-3 Fatty Acid Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Zydus Omega-3 Fatty Acid Drugs Product Portfolio Table 98. Zydus Recent Development Table 99. Woodward Pharma Company Information Table 100. Woodward Pharma Business Overview Table 101. Woodward Pharma Omega-3 Fatty Acid Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Woodward Pharma Omega-3 Fatty Acid Drugs Product Portfolio Table 103. Woodward Pharma Recent Development Table 104. Sun Pharma Company Information Table 105. Sun Pharma Business Overview Table 106. Sun Pharma Omega-3 Fatty Acid Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Sun Pharma Omega-3 Fatty Acid Drugs Product Portfolio Table 108. Sun Pharma Recent Development Table 109. Strides Pharma Company Information Table 110. Strides Pharma Business Overview Table 111. Strides Pharma Omega-3 Fatty Acid Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Strides Pharma Omega-3 Fatty Acid Drugs Product Portfolio Table 113. Strides Pharma Recent Development Table 114. PuraCap Pharmaceuticals Company Information Table 115. PuraCap Pharmaceuticals Business Overview Table 116. PuraCap Pharmaceuticals Omega-3 Fatty Acid Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. PuraCap Pharmaceuticals Omega-3 Fatty Acid Drugs Product Portfolio Table 118. PuraCap Pharmaceuticals Recent Development Table 119. Mankind Pharma Company Information Table 120. Mankind Pharma Business Overview Table 121. Mankind Pharma Omega-3 Fatty Acid Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Mankind Pharma Omega-3 Fatty Acid Drugs Product Portfolio Table 123. Mankind Pharma Recent Development Table 124. Hikma Company Information Table 125. Hikma Business Overview Table 126. Hikma Omega-3 Fatty Acid Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Hikma Omega-3 Fatty Acid Drugs Product Portfolio Table 128. Hikma Recent Development Table 129. GLW Pharma Company Information Table 130. GLW Pharma Business Overview Table 131. GLW Pharma Omega-3 Fatty Acid Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. GLW Pharma Omega-3 Fatty Acid Drugs Product Portfolio Table 133. GLW Pharma Recent Development Table 134. Dr. Reddy's Laboratories Company Information Table 135. Dr. Reddy's Laboratories Business Overview Table 136. Dr. Reddy's Laboratories Omega-3 Fatty Acid Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Dr. Reddy's Laboratories Omega-3 Fatty Acid Drugs Product Portfolio Table 138. Dr. Reddy's Laboratories Recent Development Table 139. Ascent Pharmaceuticals Company Information Table 140. Ascent Pharmaceuticals Business Overview Table 141. Ascent Pharmaceuticals Omega-3 Fatty Acid Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Ascent Pharmaceuticals Omega-3 Fatty Acid Drugs Product Portfolio Table 143. Ascent Pharmaceuticals Recent Development Table 144. Apotex Company Information Table 145. Apotex Business Overview Table 146. Apotex Omega-3 Fatty Acid Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Apotex Omega-3 Fatty Acid Drugs Product Portfolio Table 148. Apotex Recent Development Table 149. Amneal Pharmaceuticals Company Information Table 150. Amneal Pharmaceuticals Business Overview Table 151. Amneal Pharmaceuticals Omega-3 Fatty Acid Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Amneal Pharmaceuticals Omega-3 Fatty Acid Drugs Product Portfolio Table 153. Amneal Pharmaceuticals Recent Development Table 154. Amarin Pharmaceuticals Company Information Table 155. Amarin Pharmaceuticals Business Overview Table 156. Amarin Pharmaceuticals Omega-3 Fatty Acid Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Amarin Pharmaceuticals Omega-3 Fatty Acid Drugs Product Portfolio Table 158. Amarin Pharmaceuticals Recent Development Table 159. Key Raw Materials Table 160. Raw Materials Key Suppliers Table 161. Omega-3 Fatty Acid Drugs Distributors List Table 162. Omega-3 Fatty Acid Drugs Customers List Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. Omega-3 Fatty Acid Drugs Product Image Figure 2. Global Omega-3 Fatty Acid Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Omega-3 Fatty Acid Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Omega-3 Fatty Acid Drugs Sales (2021-2032) & (K Units) Figure 5. Global Omega-3 Fatty Acid Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Omega-3 Fatty Acid Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. EPA Image Figure 10. EPA and DHA Image Figure 11. Global Omega-3 Fatty Acid Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Omega-3 Fatty Acid Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Omega-3 Fatty Acid Drugs Sales Volume Share by Type (2021-2032) Figure 14. Global Omega-3 Fatty Acid Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Omega-3 Fatty Acid Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Omega-3 Fatty Acid Drugs Sales Value Share by Type (2021-2032) Figure 17. Hospital Pharmacy Image Figure 18. Retail Pharmacy Image Figure 19. Online Pharmacy Image Figure 20. Global Omega-3 Fatty Acid Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Omega-3 Fatty Acid Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Omega-3 Fatty Acid Drugs Sales Volume Share by Application (2021-2032) Figure 23. Global Omega-3 Fatty Acid Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Omega-3 Fatty Acid Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Omega-3 Fatty Acid Drugs Sales Value Share by Application (2021-2032) Figure 26. Global Omega-3 Fatty Acid Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Omega-3 Fatty Acid Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Omega-3 Fatty Acid Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Omega-3 Fatty Acid Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Omega-3 Fatty Acid Drugs Sales Value (2021-2032) & (US$ Million) Figure 31. North America Omega-3 Fatty Acid Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Omega-3 Fatty Acid Drugs Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Omega-3 Fatty Acid Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Omega-3 Fatty Acid Drugs Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Omega-3 Fatty Acid Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Omega-3 Fatty Acid Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. South America Omega-3 Fatty Acid Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Omega-3 Fatty Acid Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Omega-3 Fatty Acid Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Omega-3 Fatty Acid Drugs Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Omega-3 Fatty Acid Drugs Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • EPA
  • EPA and DHA
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
Companies covered
  • Teva
  • Sichuan Gowell Pharmaceutical
  • Humanwell Puracap Pharmaceuticals
  • Qilu Pharmaceutical
  • Jiangsu Wangao Pharmaceutical
  • Chengdu Suncadia Medicine
  • Zydus
  • Woodward Pharma
  • Sun Pharma
  • Strides Pharma
  • PuraCap Pharmaceuticals
  • Mankind Pharma
  • Hikma
  • GLW Pharma
  • Dr. Reddy's Laboratories
  • Ascent Pharmaceuticals
  • Apotex
  • Amneal Pharmaceuticals
  • Amarin Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Omega-3 Fatty Acid Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Omega-3 Fatty Acid Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Omega-3 Fatty Acid Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Omega-3 Fatty Acid Drugs Market Dynamics
  1. 2.1 Omega-3 Fatty Acid Drugs Industry Trends
  2. 2.2 Omega-3 Fatty Acid Drugs Industry Drivers
  3. 2.3 Omega-3 Fatty Acid Drugs Industry Opportunities and Challenges
  4. 2.4 Omega-3 Fatty Acid Drugs Industry Restraints
3 Omega-3 Fatty Acid Drugs Market by Company
  1. 3.1 Global Omega-3 Fatty Acid Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Omega-3 Fatty Acid Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Omega-3 Fatty Acid Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Omega-3 Fatty Acid Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Omega-3 Fatty Acid Drugs Company Ranking (2024-2026)
  6. 3.6 Global Omega-3 Fatty Acid Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Omega-3 Fatty Acid Drugs Company Product Type and Application
  8. 3.8 Global Omega-3 Fatty Acid Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Omega-3 Fatty Acid Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Omega-3 Fatty Acid Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Omega-3 Fatty Acid Drugs Market by Type
  1. 4.1 Omega-3 Fatty Acid Drugs Type Introduction
  2. 4.1.1 EPA
  3. 4.1.2 EPA and DHA
  4. 4.2 Global Omega-3 Fatty Acid Drugs Sales Volume by Type
  5. 4.2.1 Global Omega-3 Fatty Acid Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Omega-3 Fatty Acid Drugs Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Omega-3 Fatty Acid Drugs Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Omega-3 Fatty Acid Drugs Sales Value by Type
  9. 4.3.1 Global Omega-3 Fatty Acid Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Omega-3 Fatty Acid Drugs Sales Value by Type (2021-2032)
  11. 4.3.3 Global Omega-3 Fatty Acid Drugs Sales Value Share by Type (2021-2032)
5 Omega-3 Fatty Acid Drugs Market by Application
  1. 5.1 Omega-3 Fatty Acid Drugs Application Introduction
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 Online Pharmacy
  5. 5.2 Global Omega-3 Fatty Acid Drugs Sales Volume by Application
  6. 5.2.1 Global Omega-3 Fatty Acid Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Omega-3 Fatty Acid Drugs Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Omega-3 Fatty Acid Drugs Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Omega-3 Fatty Acid Drugs Sales Value by Application
  10. 5.3.1 Global Omega-3 Fatty Acid Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Omega-3 Fatty Acid Drugs Sales Value by Application (2021-2032)
  12. 5.3.3 Global Omega-3 Fatty Acid Drugs Sales Value Share by Application (2021-2032)
6 Omega-3 Fatty Acid Drugs Regional Sales and Value Analysis
  1. 6.1 Global Omega-3 Fatty Acid Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Omega-3 Fatty Acid Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Omega-3 Fatty Acid Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Omega-3 Fatty Acid Drugs Sales by Region (2027-2032)
  5. 6.3 Global Omega-3 Fatty Acid Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Omega-3 Fatty Acid Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Omega-3 Fatty Acid Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Omega-3 Fatty Acid Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Omega-3 Fatty Acid Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Omega-3 Fatty Acid Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Omega-3 Fatty Acid Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Omega-3 Fatty Acid Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Omega-3 Fatty Acid Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Omega-3 Fatty Acid Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Omega-3 Fatty Acid Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Omega-3 Fatty Acid Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Omega-3 Fatty Acid Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Omega-3 Fatty Acid Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Omega-3 Fatty Acid Drugs Sales Value Share by Country, 2025 VS 2032
7 Omega-3 Fatty Acid Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Omega-3 Fatty Acid Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Omega-3 Fatty Acid Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Omega-3 Fatty Acid Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Omega-3 Fatty Acid Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Omega-3 Fatty Acid Drugs Sales by Country (2027-2032)
  6. 7.4 Global Omega-3 Fatty Acid Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Omega-3 Fatty Acid Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Omega-3 Fatty Acid Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Omega-3 Fatty Acid Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Omega-3 Fatty Acid Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Omega-3 Fatty Acid Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Omega-3 Fatty Acid Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Omega-3 Fatty Acid Drugs Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Sichuan Gowell Pharmaceutical
  8. 8.2.1 Sichuan Gowell Pharmaceutical Company Information
  9. 8.2.2 Sichuan Gowell Pharmaceutical Business Overview
  10. 8.2.3 Sichuan Gowell Pharmaceutical Omega-3 Fatty Acid Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sichuan Gowell Pharmaceutical Omega-3 Fatty Acid Drugs Product Portfolio
  12. 8.2.5 Sichuan Gowell Pharmaceutical Recent Developments
  13. 8.3 Humanwell Puracap Pharmaceuticals
  14. 8.3.1 Humanwell Puracap Pharmaceuticals Company Information
  15. 8.3.2 Humanwell Puracap Pharmaceuticals Business Overview
  16. 8.3.3 Humanwell Puracap Pharmaceuticals Omega-3 Fatty Acid Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Humanwell Puracap Pharmaceuticals Omega-3 Fatty Acid Drugs Product Portfolio
  18. 8.3.5 Humanwell Puracap Pharmaceuticals Recent Developments
  19. 8.4 Qilu Pharmaceutical
  20. 8.4.1 Qilu Pharmaceutical Company Information
  21. 8.4.2 Qilu Pharmaceutical Business Overview
  22. 8.4.3 Qilu Pharmaceutical Omega-3 Fatty Acid Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Qilu Pharmaceutical Omega-3 Fatty Acid Drugs Product Portfolio
  24. 8.4.5 Qilu Pharmaceutical Recent Developments
  25. 8.5 Jiangsu Wangao Pharmaceutical
  26. 8.5.1 Jiangsu Wangao Pharmaceutical Company Information
  27. 8.5.2 Jiangsu Wangao Pharmaceutical Business Overview
  28. 8.5.3 Jiangsu Wangao Pharmaceutical Omega-3 Fatty Acid Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Jiangsu Wangao Pharmaceutical Omega-3 Fatty Acid Drugs Product Portfolio
  30. 8.5.5 Jiangsu Wangao Pharmaceutical Recent Developments
  31. 8.6 Chengdu Suncadia Medicine
  32. 8.6.1 Chengdu Suncadia Medicine Company Information
  33. 8.6.2 Chengdu Suncadia Medicine Business Overview
  34. 8.6.3 Chengdu Suncadia Medicine Omega-3 Fatty Acid Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Chengdu Suncadia Medicine Omega-3 Fatty Acid Drugs Product Portfolio
  36. 8.6.5 Chengdu Suncadia Medicine Recent Developments
  37. 8.7 Zydus
  38. 8.7.1 Zydus Company Information
  39. 8.7.2 Zydus Business Overview
  40. 8.7.3 Zydus Omega-3 Fatty Acid Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Zydus Omega-3 Fatty Acid Drugs Product Portfolio
  42. 8.7.5 Zydus Recent Developments
  43. 8.8 Woodward Pharma
  44. 8.8.1 Woodward Pharma Company Information
  45. 8.8.2 Woodward Pharma Business Overview
  46. 8.8.3 Woodward Pharma Omega-3 Fatty Acid Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Woodward Pharma Omega-3 Fatty Acid Drugs Product Portfolio
  48. 8.8.5 Woodward Pharma Recent Developments
  49. 8.9 Sun Pharma
  50. 8.9.1 Sun Pharma Company Information
  51. 8.9.2 Sun Pharma Business Overview
  52. 8.9.3 Sun Pharma Omega-3 Fatty Acid Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Sun Pharma Omega-3 Fatty Acid Drugs Product Portfolio
  54. 8.9.5 Sun Pharma Recent Developments
  55. 8.10 Strides Pharma
  56. 8.10.1 Strides Pharma Company Information
  57. 8.10.2 Strides Pharma Business Overview
  58. 8.10.3 Strides Pharma Omega-3 Fatty Acid Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Strides Pharma Omega-3 Fatty Acid Drugs Product Portfolio
  60. 8.10.5 Strides Pharma Recent Developments
  61. 8.11 PuraCap Pharmaceuticals
  62. 8.11.1 PuraCap Pharmaceuticals Company Information
  63. 8.11.2 PuraCap Pharmaceuticals Business Overview
  64. 8.11.3 PuraCap Pharmaceuticals Omega-3 Fatty Acid Drugs Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 PuraCap Pharmaceuticals Omega-3 Fatty Acid Drugs Product Portfolio
  66. 8.11.5 PuraCap Pharmaceuticals Recent Developments
  67. 8.12 Mankind Pharma
  68. 8.12.1 Mankind Pharma Company Information
  69. 8.12.2 Mankind Pharma Business Overview
  70. 8.12.3 Mankind Pharma Omega-3 Fatty Acid Drugs Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Mankind Pharma Omega-3 Fatty Acid Drugs Product Portfolio
  72. 8.12.5 Mankind Pharma Recent Developments
  73. 8.13 Hikma
  74. 8.13.1 Hikma Company Information
  75. 8.13.2 Hikma Business Overview
  76. 8.13.3 Hikma Omega-3 Fatty Acid Drugs Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Hikma Omega-3 Fatty Acid Drugs Product Portfolio
  78. 8.13.5 Hikma Recent Developments
  79. 8.14 GLW Pharma
  80. 8.14.1 GLW Pharma Company Information
  81. 8.14.2 GLW Pharma Business Overview
  82. 8.14.3 GLW Pharma Omega-3 Fatty Acid Drugs Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 GLW Pharma Omega-3 Fatty Acid Drugs Product Portfolio
  84. 8.14.5 GLW Pharma Recent Developments
  85. 8.15 Dr. Reddy's Laboratories
  86. 8.15.1 Dr. Reddy's Laboratories Company Information
  87. 8.15.2 Dr. Reddy's Laboratories Business Overview
  88. 8.15.3 Dr. Reddy's Laboratories Omega-3 Fatty Acid Drugs Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Dr. Reddy's Laboratories Omega-3 Fatty Acid Drugs Product Portfolio
  90. 8.15.5 Dr. Reddy's Laboratories Recent Developments
  91. 8.16 Ascent Pharmaceuticals
  92. 8.16.1 Ascent Pharmaceuticals Company Information
  93. 8.16.2 Ascent Pharmaceuticals Business Overview
  94. 8.16.3 Ascent Pharmaceuticals Omega-3 Fatty Acid Drugs Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Ascent Pharmaceuticals Omega-3 Fatty Acid Drugs Product Portfolio
  96. 8.16.5 Ascent Pharmaceuticals Recent Developments
  97. 8.17 Apotex
  98. 8.17.1 Apotex Company Information
  99. 8.17.2 Apotex Business Overview
  100. 8.17.3 Apotex Omega-3 Fatty Acid Drugs Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Apotex Omega-3 Fatty Acid Drugs Product Portfolio
  102. 8.17.5 Apotex Recent Developments
  103. 8.18 Amneal Pharmaceuticals
  104. 8.18.1 Amneal Pharmaceuticals Company Information
  105. 8.18.2 Amneal Pharmaceuticals Business Overview
  106. 8.18.3 Amneal Pharmaceuticals Omega-3 Fatty Acid Drugs Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Amneal Pharmaceuticals Omega-3 Fatty Acid Drugs Product Portfolio
  108. 8.18.5 Amneal Pharmaceuticals Recent Developments
  109. 8.19 Amarin Pharmaceuticals
  110. 8.19.1 Amarin Pharmaceuticals Company Information
  111. 8.19.2 Amarin Pharmaceuticals Business Overview
  112. 8.19.3 Amarin Pharmaceuticals Omega-3 Fatty Acid Drugs Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Amarin Pharmaceuticals Omega-3 Fatty Acid Drugs Product Portfolio
  114. 8.19.5 Amarin Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Omega-3 Fatty Acid Drugs Value Chain Analysis
  2. 9.1.1 Omega-3 Fatty Acid Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Omega-3 Fatty Acid Drugs Sales Mode & Process
  6. 9.2 Omega-3 Fatty Acid Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Omega-3 Fatty Acid Drugs Distributors
  9. 9.2.3 Omega-3 Fatty Acid Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst